Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: BJU Int. 2011 Jul 14;109(5):713–719. doi: 10.1111/j.1464-410X.2011.10292.x

Table 3. Treatment details for the seven BRCA carriers studied.

Patient BRCA Age (years) Treatment Response PSA level at treatment start PSA nadir within 12 weeks % change in PSA level Treatment to death (months)
1 1 77 D No 3 8 220 4.1
2 1 82 D Yes 44 20 −53 16.9
3 1 88 D No 199 294 48 2.1
4 2 59 D Yes 811 179 −78 8.1
5 2 64 D+carboplatin Yes 2 1 −62 37
6 2 78 D+estramustine No 1110 1115 0.5 10.1
7 2 72 D Yes 250 88 −65 17.4

D, docetaxel.